4DMedical Reports 23% Rise in Fiscal 2026 Operating Revenue; Shares Up 8%

MT Newswires Live
Jul 31

4DMedical (ASX:4DX) said operating revenue for fiscal 2026 was AU$7.2 million, up 23% on the prior corresponding period, driven by increased paid scan volume, according to a Friday Australian bourse filing.

The company said it is now delivering software-as-a-service (SaaS) products at 540 sites globally, up 39% year on year, producing a record fourth quarter of 105,970 scans, up 43% on the prior corresponding period.

Cash balance stood at AU$278 million as of June 30, with the company also completing the acquisition of European lung imaging artificial intelligence company Contextflow after quarter-end following approval from Austrian Foreign Direct Investment authorities and all required regulatory approvals, the filing added.

The company's shares rose past 8% in recent Friday trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10